Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DengiAll
- Development stage
- Phase 3
- Lead developer
- Panacea Biotec
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
DengiAll is a tetravalent recombinant live attenuated vaccine designed to protect against all four serotypes of the dengue virus (DENV-1, DENV-2, DENV-3, and DENV-4). It is being developed as India's first indigenous dengue vaccine and aims to address the significant public health burden of dengue fever in tropical and subtropical regions. The vaccine is based on the TV003/TV005 strain originally developed by the National Institutes of Health (NIH) and has been further advanced by Panacea Biotec in collaboration with the Indian Council of Medical Research (ICMR). Its mechanism involves immunostimulation to induce protective immunity against all four serotypes. As of April 2025, it is undergoing Phase 3 clinical trials across multiple sites in India[1][3][4][5][7].
- Brand names
- DengiAll
- Other names
- Tetravalent dengue Vaccine Panacea Biotec
Beyond the preview
Go deeper on DengiAll.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DengiAll.